Cargando…
Metformin Ameliorates Aβ Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer's Disease
Alzheimer's disease (AD) is the most common neurodegenerative disease. The accumulation of amyloid beta (Aβ) is the main pathology of AD. Metformin, a well-known antidiabetic drug, has been reported to have AD-protective effect. However, the mechanism is still unclear. In this study, we tried t...
Autores principales: | Lu, Xin-Yi, Huang, Shun, Chen, Qu-Bo, Zhang, Dapeng, Li, Wanyan, Ao, Ran, Leung, Feona Chung-Yin, Zhang, Zhimin, Huang, Jisheng, Tang, Ying, Zhang, Shi-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191377/ https://www.ncbi.nlm.nih.gov/pubmed/32377293 http://dx.doi.org/10.1155/2020/2315106 |
Ejemplares similares
-
Schisandra A ameliorates cigarette smoke extract and lipopolysaccharide-induced oxidative stress in lung epithelial cells
por: Zhang, Dapeng, et al.
Publicado: (2020) -
Does Chronic Kidney Disease Result in High Risk of Atrial Fibrillation?
por: Zhang, Dapeng, et al.
Publicado: (2019) -
Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme
por: Cordes, Crystal M., et al.
Publicado: (2011) -
Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
por: Du, Xuan, et al.
Publicado: (2018) -
Targeting Insulin-Degrading Enzyme in Insulin Clearance
por: Leissring, Malcolm A., et al.
Publicado: (2021)